TABLE-Noile-Immune Biotech - 9-MTH parent results

About this update from Noile-immune Biotech Inc.

Nov 13 (Reuters)- Noile-Immune Biotech Inc. PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Sep 30, 2025 Sep 30, 2024 Dec 31, 2025 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 5 mln 5 mln 5 mln (-8.2 pct) (-98.3 pct) (-34.1 pct) Operating loss 608 mln loss 892 mln loss 812 mln Recurring loss 602 mln loss 785 mln loss 806 mln Net loss 605 mln loss 787 mln loss 809 mln EPS loss 13.97 yen loss 18.18 yen loss 18.70 yen Ann Div NIL NIL -Q2 div NIL NIL -Q4 div NIL NIL NOTE - Noile-Immune Biotech Inc.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T

View stock analysis, news, and events for Noile-immune Biotech Inc.